Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

3 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
4(50.0%)
Phase 4
2(25.0%)
Phase 2
1(12.5%)
Phase 3
1(12.5%)
8Total
N/A(4)
Phase 4(2)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT06871150Not ApplicableRecruiting

Three Different GHDT ( Goal Hemodynamic Directed Therapy) Strategies for Intraoperative Fluid Management Optimization During Major Abdominal Surgery: A Randomized Controlled Trial

Role: collaborator

NCT07428018Phase 2Not Yet Recruiting

Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib

Role: collaborator

NCT06440629Phase 4Recruiting

Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)

Role: collaborator

NCT05271786Completed

WEANING FROM TRACHEOSTOMY

Role: collaborator

NCT07061379Recruiting

Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen

Role: collaborator

NCT07019077Recruiting

Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagulants Compared to Non-anticoagulated Patients

Role: collaborator

NCT04617587Not ApplicableCompleted

Novel Epigenetic Biomarker for Prematurity Related Neurodevelopmental Disorders in Childhood

Role: collaborator

NCT06720961Not Yet Recruiting

The Microbial Impact on Intestinal Fibrosis and the Associated Immune Microenvironment in Crohn's Disease

Role: collaborator

NCT06805812Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Role: collaborator

NCT06746909Not ApplicableRecruiting

Identification of Neuroinflammation and Neuroimaging Biomarkers Through Data Driven Artificial Intelligence Techniques for Unraveling the Heterogeneity of Aged Subjects at Risk of Dementia and to Better Inform Prevention Strategies

Role: collaborator

NCT06730464Recruiting

Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy

Role: collaborator

NCT05249192Not ApplicableCompleted

Immediate Versus Early (24-hours) Urinary Catheter Removal After Elective Minimally Invasive Colonic Resection

Role: collaborator

NCT06708819Not Yet Recruiting

AUGUR-AI - Indocyanine Green Fluorescence Angiography Representer

Role: collaborator

NCT05637944Unknown

ThoRAciC Trauma IntubatiON Risk Score for Blunt Trauma

Role: collaborator

NCT06192524Unknown

OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry

Role: collaborator

NCT05448092Unknown

Registry for Evaluation of Lumbar Arthrodesis Sagittal alignmEnt

Role: collaborator

NCT05803122Completed

Validation of the I-UDS Neuropsychological Battery

Role: collaborator

NCT05228912Completed

Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.

Role: collaborator

NCT03827577Phase 3Unknown

OMEGA, Local Ablative Therapy in Oligometastatic NSCLC

Role: collaborator

NCT02509754Phase 4Unknown

Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function

Role: collaborator

All 20 trials loaded